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Introduction
Obesity either in the form of raised body mass index (BMI)
or excess body fat (BF) deposition is exceedingly harmful
for the human body. Decreased exercise, sedentary
lifestyles and inappropriate dietary habits, combined with
a "thrifty genotype" have made obesity a global
pandemic. In Pakistan more than 22 per cent individuals
over 15 years are obese.1 Obesity not only has
psychosocial issues like low self-esteem, but it
predisposes a person to other life-threatening
complications such as cardiovascular diseases, type II
diabetes, high blood cholesterol levels etc.2 Of these
myriad effects of obesity, the effects on the vitamin D and
leptin levels and their effect on maintenance of bone
mineral density (BMD) in obese individuals are highly
intriguing.
Other than dietary sources like fish, cheese and eggs, skin
also contributes towards the vitamin D (cholecalciferol)
pool when it is exposed to ultraviolet (UV) radiation from
the sun, which is converted to its active form in the
kidney.3 This vitamin is essential for early development
and growth and is known to play an integral role in
maintaining BMD.4 The role of vitamin D is to enhance the
absorption of calcium, phosphorus, magnesium and zinc
from the gut. Deficiency of vitamin D leads to a number
of diseases in children such as rickets and osteomalacia
and increases the risk for certain cancers, multiple
sclerosis, hypertension and type 1 diabetes in adults.5
Since vitamin D is fat-soluble, it tends to get sequestered
in fat tissues and obese individuals may develop an
apparent deficiency.6 Ironically, these reduced levels do
not appear to affect the bone mass in obese individuals. In
fact, increased BMI has been associated with increased
BMD by previous studies, possibly because increased BMI
increases mechanical stress on the bones resulting in an
amplified BMD.7
On the other hand, leptin, a satiety hormone released by
adipocytes is the product of obese (ob) gene.8 It primarily
regulates the fat content of the body. Leptin levels
increase after a meal and act on satiety centres in arcuate
nucleus of the hypothalamus. Increase in BF also causes
an increase in baseline leptin levels. Obese people often
have hyperleptinaemia because they usually develop
leptin resistance,9 therefore the satiety function of leptin
gets depressed. Other known effects of leptin are its
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Abstract
Objectives: To estimate leptin, vitamin D and bone mineral density levels in individuals with high fat mass, and to
assess any correlation.
Methods: The cross-sectional study was conducted at the Basic Medical Sciences Institute, Jinnah Post Graduate
Medical Centre, Karachi, and Aga Khan University, Karachi, from August 2012 to July 2014, and comprised healthy
male volunteers between the ages of 18-60 years. Body fat percentage was determined using bioelectrical
impedance analysis and the participants were classified as: Group A (15-21.9); Group B (22-27.9); and Group C (>28).
Bone mineral density was calculated by ultrasound bone densitometer (T-score between +1 and ?1 considered
normal). Enzyme-linked immunosorbent assay kits were used to determine the levels of vitamin D and leptin. SPSS
19 was used for statistical analysis.
Results: A total of 132 male subjects participated in this study, with each of the 3 groups having 44(33.3%). Despite
all groups having low Vitamin D, a marked decrease was observed in group C compared to groups A and B (p
<0.018). Bone mineral density T-score was <-1; total calcium was within normal range in all three groups. Serum
leptin was raised in Group C compared to group A and B (p=0.03). Body fat percentage was negatively associated
with vitamin D (p=0.004; r = -0.351), while it was positively correlated with leptin (p =0.038; r = 0.256).
Conclusion: Excess of body fat percentage led to decreased vitamin D and raised leptin. However, bone mineral
density and calcium levels were within normal range, suggesting that other factors might have played a role in
maintaining bone mass in obese individuals, such as leptin.
Keywords: Obesity, Bone weight, Leptin, Vitamin D, Bioelectric impedance analysis, Bone mineral density.
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effects on the nervous and endocrine systems, especially
the hypothalamic-pituitary-gonadal axis and insulin
biology.10 Some studies have also suggested that leptin
causes increased osteoblastic differentiation and inhibits
osteoclast generation, therefore decreasing bone
resorption and increasing bone mass.11 Nevertheless the
role of leptin on bone regulation is still highly
controversial with different authors suggesting diverse
associations.
The relation of BMD, leptin and vitamin D in obesity is not
well understood. A number of previous studies have
associated excess body fat mass with decreased vitamin
D, increased bone mass and increased levels of leptin.7,9,12
The current study was planned to estimate the circulatory
levels of vitamin D and leptin along with BMD levels in
individuals with high fat mass and to assess their
correlation.
Subjects and Methods
The cross-sectional study was conducted at the Basic
Medical Sciences Institute (BMSI), Jinnah Post Graduate
Medical Centre (JPMC), Karachi, and Aga Khan University
(AKU), Karachi, from August 2012 to July 2014, and
comprised healthy male volunteers between the ages of
18-60 years.
Body fat percentage (BF%) was estimated by bioelectrical
impedance analysis using Diagnostic Scale BG55 (Beurer,
Germany). Subjects were asked to stand on the machine
in light clothing and in an erect posture. The participants
were classified as: Group A (15-21.9); Group B (22-27.9);
and Group C (>28).13
In order to achieve minimum 80% power with a 15%
estimated prevalence of obesity and a two-sided 5% level
of significance, the minimum sample size required,
according to Power and Sample Size (PASS) version 11,
was 44 for each group.
BF% was measured after the study was approved by the
ethics review committee of MBSI And all participants gave
written informed consent.
Height was measured using a standard stadiometer (ZT -
120 Health Scale, made in China). BMI was calculated
using the following formula: weight in kg / height in m2).14
The following was used as reference values for BMI;
normal weight 18.0-22.9 kg/m2, overweight 23.0-
25.9kg/m2), and obese >26.0 kg/m2 as per the South Asian
criteria.15 Waist and hip circumference along with their
ratio was measured as previously described.16
The heel bone (calcaneous) BMD was measured using an
ultrasound bone densitometer (OsteosysSonost 3000
Bone Densitometry). A T-score between +1 and -1 was
considered normal or healthy.17
Three ml of blood was collected in sterile Venoject tubes
after an overnight fast of 8-12 hours. Blood was
centrifuged at 2000xg for 5 minutes to separate the
serum. Serum was further aliquoted in small volumes and
stored at -80ºC until further use.
Vitamin D and leptin levels were measured by
commercially available enzyme-linked immunosorbent
assay (ELISA) kits (kit cat#KAP197; kit cat# KAP2281 by DIA
source Immunoassays S.A. Belgium respectively). The
following reference range for vitamin D levels were
considered; deficient <10 ng/ml, insufficient =10-29
ng/ml, sufficient = 30-100 ng/ml and toxic = >100
ng/ml.[18] Serum calcium was estimated by automated
clinical analysers (Roche).19
SPSS 19 was used for statistical analysis. Data on
continuous variables, such as age, height, weight, BMI,
waist circumference, hip circumference, waist-hip ratio,
BF%, BMD, and biochemical (serum calcium, vitamin D
and leptin) parameters were calculated as mean ±
standard deviation (SD). Mann-Whitney U test was used to
compare groups. Spearman's coefficient of correlation (r)
was used to determine the correlation between serum
vitamin D, leptin levels, BF parameters and BMD. In all
statistical analysis, p<0.05 was considered significant.
Results
A total of 180 individuals volunteered for the study, but
48(26.6%) were excluded on the basis of history of recent
illness in the preceding six weeks, chronic diseases like
diabetes, tuberculosis, cancer or hypertension, and
supplementation of vitamin D or calcium. A total of
132(73.3%) male subjects participated in the study, with
each of the three groups having 44(33.3%) subjects. All
subjects were age-matched and therefore no significant
differences were observed among the groups.
Biochemical and biophysical parameters of the subjects
were noted (Table).
In all the study groups, values of BMD T-score was in the
lower threshold (i.e. <-1); similarly all groups showed
normal total calcium levels (mg/dl) (p>0.05). Despite all
groups having low levels of Vitamin D, a marked decrease
was observed in Group C compared to groups A and B (p
=0.018). The low levels of vitamin D, however, did not have
any effect on the calcium levels or the bone mass of these
individuals. Serum leptin concentration was significantly
increased in Group C compared to groups A and group B
(p=0.03).
Total BF% was negatively associated with circulating
vitamin D concentrations (p =0.004; r = -0.351) while at
the same time it was positively correlated with leptin
levels (p =0.038; r = 0.256) (Figure-1A-B).
Discussion
Relation of vitamin D and leptin with BF% is scarce,
specially in Pakistani population. This popuation, being
overtly vitamin D-deficient without showing any obvious
signs of decremental BMD, renders itself as a target for
investigating the link between body fat, vitamin D and
leptin with bone mass. To address this, we estimated the
levels of vitamin D, leptin and BMD in varying degrees of
adiposity and studied their correlation. The present study
yielded interesting results, showing that the overall study
cohort had low vitamin D levels despite having normal
serum calcium. The low vitamin D level is perhaps now
considered a common finding among the South Asian
population as documented in studies done earlier.20,21
The current study determined that with increased BF%
and vitamin D levels further decreased without affecting
the bone mineralisation. This unusual relation of low
J Pak Med Assoc
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Table: Biophysical characteristics.
Parameter Group A Group B Group C P value
Normal weight (n=44) Overweight (n=44) Obese (n=44)
Mean ± SD Mean ± SD Mean ± SD
Age (years) 35.7 ± 11.6 37.2 ± 12.1 39.3 ± 11.0 >0.05
Weight (kg) 58.7 ± 9.3 70.9 ± 8.00 78.8 ± 12.5** <0.001
BMI (kg/m2) 19.6 ± 2.0 24.5 ± 2.35** 28.9 ± 7.2** <0.001
Body fat % 15.7 ± 3.8 25.4 ± 2.27** 34.7 ± 5.2** <0.001
Waist circumference (cm) 71.8 ± 7.6 89.4 ± 9.05 96.0 ± 14.9** <0.001
Hip circumference(cm) 85.6 ± 8.7 102.8 ± 9.08 102.7 ± 15.6 <0.001
WHR 0.8 ± 0.0 0.88 ± 0.085 0.9 ± 0.1** <0.001
BMD value (T-score) -1.34 ± 0.6 -1.39 ± 1.09 -1.2 ± 0.6 0.264
BMD % 78.8 ± 9.6 74.6 ± 17.99 80.6 ± 11.6 0.227
Bone weight 8.34 ± 1.7 9.57 ± 1.42 10.0 ± 6.8 0.707
Vitamin D (ng/ml) 12.8 ± 2.1 9.4 ± 2.10 7.2 ± 1.4* 0.018
Leptin (ng/ml) 4.7 ± 0.9 5.51 ± 1.90 8.3 ± 1.3* 0.030
Calcium (mg/dl) 8.8 ± 0.4 8.82 ± 0.49 9.0 ± 0.7 0.525
BMI: Body mass index
WHR: Waist-hip ratio)
BMD: Bone mineral density.
*Statistically significant as compared to control subjects, where p<0.05.
**Statistically significant as compared to control subjects, where p<0.01.
Figure (A-B): Correlation Graphs.
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vitamin D, normal calcium and a postitive correlation with
bone mineralisation is in line with a previous study.22 The
lower levels might be due to vitamin D sequesterion in
adipose tissue, resulting in reduced levels in the blood.
The reasons for such a finding to prevail in most studies
points towards genetic polymorphisms, leading to
hypovitaminosis D. Further research to identify relevent
gene polymorphism might be able to shed more light to
this intriquing pheneomenon.
It is also possible that the reduced vitamin D levels may
cause obesity in these individuals as suggested by a
previous study.23 The reduced vitamin D levels may
enhance the capacity of the body to store large amounts
of fat as a stress response, to ensure better survival. The
bone density of the study population revealed no
significant difference despite the differences in the
vitamin D levels. In fact, the obese population with lower
vitamin D levels still had a BMD closer to normal as
opposed to those with a relatively higher vitamin D level.
An earlier study12 found that adolescents between 10-16
years of age with obesity had lower vitamin D serum
concentration, but had higher age-adjusted BMD than
lean subjects.
This was a very thought-provoking finding, suggestive of
something additional than vitamin D is playing a part in
bone mineralisation. The best candidate for this
hyposthesis in our study would be increased leptin levels
in the obese subjects. As serum leptin concentrations are
elevated in obesity, a favourable effect of raised leptin on
BMD might play a part in maintaining bone
mineralisation,24 resulting in a better BMD value in our
population of interest, although the factual reason was
beyond the scope of our study and a large sample size ie
required to validate this finding. On the other hand, some
studies have shown to have a contradictory opinion to
this idea.25 Therefore the increased BMD can possibly be
caused by the increased weight loading/stress on the
bone which occurs in obesity.
The limitations of the study are owing to its cross-
sectional design, due to which a causal relation between
these factors could not be implied. Moreover, the role of
certain hormones such as of oestrogen, parathyroid
hormone (PTH), etc. could not be evaluated. Future
longitudinal studies inlcuding these factors as well as
identifying genetic polymorphisms for vitamin D receptor
and collagen synthesis genes are required to elucidate the
role of genetic factors maintianing BMD and calcium
levels despite hypovitaminosis D in Pakistani population.
Conclusion
Decreased levels of vitamin D were associated with higher
body fat mass probably due to its sequestration within
the adipocytes. Despite low viatmin D, there was no
change noticed in BMD which may highlight the bone
minerasiation effects of raised leptin. But further
longitudinal studies are required to clarify these findings.
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